Skip to main content
Fig. 5 | BMC Medical Genetics

Fig. 5

From: Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method

Fig. 5

Odds ratio of case-control status. Individuals in the independent ANZ cohort were partitioned into 10 groups on the basis of the rank of their predicted risk score from BayesR, EN, GBLUP, and GPRS. The first decile is used as the reference group. The vertical bars denote mean and 95% confidence intervals from 5-fold cross-validation. The discovery populations included 123,437 iChip SNPs and 43,900 and 40,050 individuals for CD and UC, respectively

Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us